JMP Securities Downgrades Intellia Therapeutics (NTLA) to Market Perform
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $11.91 +0.68%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JMP Securities analyst Silvan Tuerkcan downgraded Intellia Therapeutics (NASDAQ: NTLA) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Intellia Therapeutics click here. For more ratings news on Intellia Therapeutics click here.
Shares of Intellia Therapeutics closed at $36.08 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- JPMorgan Downgrades KinderCare Learning Companies (KLC) to Underweight
- HSBC Downgrades Cisco (CSCO) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
